Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis
- PMID: 22131855
- PMCID: PMC3206105
Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis
Abstract
It has recently been shown that taurine deficiency leads to impaired respiratory chain function, resulting in reduced ATP generation and enhanced oxidative stress. Because cardiomyopathy develops in taurine-deficient animals, the hypothesis that mitochondrial oxidative stress may contribute to the development of cardiomyocyte dysfunction and cell death was tested. Isolated neonatal cardiomyocytes incubated in medium containing the taurine transport inhibitor, beta-alanine, lost nearly one-half of their cellular taurine content after 48 h. Accompanying the loss of taurine was a time-dependent increase in apoptosis, which was prevented by the mitochondrial permeability transition inhibitor, cyclosporin A. Two taurine-dependent factors, oxidative stress and calcium overload, serve as important regulators of the mitochondrial permeability transition. Although taurine deficiency slowed the removal of calcium from the cytosol, it had no effect on diastolic calcium content and only modestly reduced systolic calcium content, suggesting that calcium overload is not the trigger for mitochondrial permeability transition pore formation. On the other hand, the glutathione redox ratio was significantly altered in the taurine-deficient cardiomyocyte, suggesting that oxidative stress is the primary initiator of mitochondrial permeability transition and apoptosis in the taurine-deficient cardiomyocyte.
Keywords: Apoptosis; Mitochondrial permeability transition; Oxidative stress; Taurine deficiency.
Figures





Similar articles
-
Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.Mol Cell Biochem. 2016 May;416(1-2):11-22. doi: 10.1007/s11010-016-2688-z. Epub 2016 Mar 29. Mol Cell Biochem. 2016. PMID: 27023909 Free PMC article.
-
Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.J Biomed Sci. 2010 Aug 24;17 Suppl 1(Suppl 1):S25. doi: 10.1186/1423-0127-17-S1-S25. J Biomed Sci. 2010. PMID: 20804600 Free PMC article.
-
Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production.Amino Acids. 2012 Jun;42(6):2223-32. doi: 10.1007/s00726-011-0962-7. Epub 2011 Jun 21. Amino Acids. 2012. PMID: 21691752
-
Roles of mitochondria in health and disease.Diabetes. 2004 Feb;53 Suppl 1:S96-102. doi: 10.2337/diabetes.53.2007.s96. Diabetes. 2004. PMID: 14749273 Review.
-
The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury.Mol Cell Biochem. 1997 Sep;174(1-2):159-65. Mol Cell Biochem. 1997. PMID: 9309681 Review.
Cited by
-
Taurine and inflammatory diseases.Amino Acids. 2014 Jan;46(1):7-20. doi: 10.1007/s00726-012-1361-4. Epub 2012 Jul 19. Amino Acids. 2014. PMID: 22810731 Free PMC article. Review.
-
The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant.Molecules. 2021 Aug 13;26(16):4913. doi: 10.3390/molecules26164913. Molecules. 2021. PMID: 34443494 Free PMC article. Review.
-
Taurine as a Natural Antioxidant: From Direct Antioxidant Effects to Protective Action in Various Toxicological Models.Antioxidants (Basel). 2021 Nov 24;10(12):1876. doi: 10.3390/antiox10121876. Antioxidants (Basel). 2021. PMID: 34942978 Free PMC article. Review.
-
Effect of taurine supplementation on preventing ventilator-associated pneumonia in pediatrics under mechanical ventilation, a randomized controlled double-blind clinical trial.Front Pediatr. 2025 Jan 10;12:1490247. doi: 10.3389/fped.2024.1490247. eCollection 2024. Front Pediatr. 2025. PMID: 39867697 Free PMC article.
-
Taurine protects against As2O3-induced autophagy in livers of rat offsprings through PPARγ pathway.Sci Rep. 2016 Jun 13;6:27733. doi: 10.1038/srep27733. Sci Rep. 2016. PMID: 27291853 Free PMC article.
References
-
- Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72:101–63. - PubMed
-
- Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr. 1999;129:1705–12. - PubMed
-
- Schuller-Levis GB, Park E. Taurine: New implications for an old amino acid. FEMS Microbiol Lett. 2003;226:195–202. - PubMed
-
- Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids. 2011. (In press) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources